GREAT POINT PARTNERS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY)

Filing manager: GREAT POINT PARTNERS LLC
Reporting owner: Great Point Partners, LLC
Security: Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: UNCY
Shares outstanding: 114,846,507 shares
Disclosed shares: 11,473,166 shares
Ownership percentage: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:39:41 UTC
Event date: 31 Dec 2024
SEC filing: View on sec.gov

Key filing fact

GREAT POINT PARTNERS LLC disclosed 10% ownership in Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY) on 31 Dec 2024.

Key facts

GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY).
Disclosed ownership: 10%.
Date of event: 31 Dec 2024.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Great Point Partners, LLC	10%	11,473,166	11,473,166	/s/ Dr. Jeffrey R. Jay, M.D	Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Dr. Jeffrey R. Jay, M.D.	10%	11,473,166	11,473,166	/s/ Dr. Jeffrey R. Jay, M.D	Dr. Jeffrey R. Jay, M.D
Ms. Lillian Nordahl	10%	11,473,166	11,473,166	/s/ Ms. Lillian Nordahl	Ms. Lillian Nordahl

CIK / CUSIP context first

Broader feeds